Arena Pharmaceuticals Inc released results from a Phase 1 clinical trial of APD916, a drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy with cataplexy. The randomized, double-blind, and pl
Read MoreResearch appearing in a recent issue of Nature Neuroscience found that rod cells are the only ones responsible for "setting" internal clocks in low light conditions. What’s more, the study found that rods also contribute (along with co
Read More
Exploring potential behavioral treatments for insomnia.
Read MoreMaking the move to an electronic health record system.
Read MoreRisk Evaluation and Mitigation Strategies (REMS) for Cephalon’s medications Nuvigil (armodafinil) Tablets [C-IV] and Provigil (modafinil) Tablets [C-IV] have been approved by the US Food and Drug Administration (FDA). Both the Nuvigil and
Read More